4//SEC Filing
PERRI ROSE C 4
Accession 0001144204-11-027214
CIK 0001059784other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:01 PM ET
Size
8.1 KB
Accession
0001144204-11-027214
Insider Transaction Report
Form 4
PERRI ROSE C
DirectorCOO, CFO, Treas. & Secy.
Transactions
- Sale
Common Stock
2011-05-06$0.23/sh−20,000$4,500→ 990,478 total
Holdings
- 1,451,246(indirect: By Estate of Mark Perri)
Common Stock
- 953,667(indirect: By GHI, Inc.)
Common Stock
- 341,496(indirect: By EBI, Inc.)
Common Stock
- 953,667(indirect: By GHI, Inc.)
Common Stock
Footnotes (4)
- [F1]This aggregate number of shares does not include 200,000 shares of common stock underlying stock options which survived the death of Mark Perri, who was the reporting person's brother.
- [F2]The reporting person may be deemed to beneficially own such 341,496 shares owed of record by EBI, Inc. because the reporting person holds the right to vote such shares.
- [F3]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares.
- [F4]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. because the reporting person holds the right to vote such shares.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeother
Related Parties
1- filerCIK 0001125858
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:01 PM ET
- Size
- 8.1 KB